Your browser doesn't support javascript.
loading
PTEN promoter methylation predicts 10-year prognosis in hormone receptor-positive early breast cancer patients who received adjuvant tamoxifen endocrine therapy.
Fan, Yu; Xie, Guiqin; Wang, Zhu; Wang, Yu; Wang, Yanping; Zheng, Hong; Zhong, Xiaorong.
Afiliación
  • Fan Y; Laboratory of Molecular Diagnosis of Cancer, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
  • Xie G; Laboratory of Molecular Diagnosis of Cancer, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
  • Wang Z; Laboratory of Molecular Diagnosis of Cancer, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
  • Wang Y; Laboratory of Molecular Diagnosis of Cancer, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
  • Wang Y; Laboratory of Molecular Diagnosis of Cancer, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
  • Zheng H; Laboratory of Molecular Diagnosis of Cancer, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
  • Zhong X; Department of Head, Neck and Mammary Gland Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
Breast Cancer Res Treat ; 192(1): 33-42, 2022 Feb.
Article en En | MEDLINE | ID: mdl-34978016

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias de la Mama Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias de la Mama Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2022 Tipo del documento: Article